Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema Treatment
Launched by THE NATIONAL INSTITUTE OF LYMPHOLOGY · Jan 10, 2011
Trial Information
Current as of May 27, 2025
Unknown status
Keywords
ClinConnect Summary
Breast cancer is a serious health issue that affects 1 in 8 women. Although numerous treatments have arisen in recent years to aggressively combat this disease and increase survivorship, many survivors develop a crippling condition that can result in devastating physical and psychological impairments. Breast reconstruction by any method may help recovery psychologically. However, some individuals still report experiencing pain following their recovery from surgery. Additionally, secondary lymphedema is a common yet poorly understood complication of breast cancer patients. For those individu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Undergoing perforator flap surgery for breast reconstruction and/or vascularized lymph node transfer for treatment of lymphedema
- Exclusion Criteria:
- • Pregnant
- • unable to read
About The National Institute Of Lymphology
The National Institute of Lymphology is a leading research organization dedicated to advancing the understanding and treatment of lymphatic disorders. With a commitment to innovative clinical trials and collaborative research, the Institute focuses on developing novel therapeutic strategies and improving patient outcomes in lymphatic health. By integrating cutting-edge science with clinical expertise, the National Institute of Lymphology aims to foster breakthroughs in lymphology, enhance public health, and contribute to the global body of knowledge in this specialized field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
New Orleans, Louisiana, United States
Charleston, South Carolina, United States
Patients applied
Trial Officials
Marga F. Massey, M.D.
Principal Investigator
National Institute of Lymphology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials